Stock Screener App

Frei -

Installieren

46.60

0.42% 0.2037

Ultragenyx Pharmaceutical Inc (RARE)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt RARE? Forum Prognose Aktiensplit

Finanzdaten der Ultragenyx Pharmaceutical Inc-Aktie (RARE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	14.57% 108.83	127.39	98.05	108.31	100.50
Operating Expenses	9.92% 274.18	249.44	243.15	256.27	254.60
Benefits Costs and Expenses	9.74% 279.06	254.28	257.05	267.40	263.97
Costs And Expenses	9.74% 279.06	254.28	257.05	267.40	263.97
Operating Income/Loss	35.48% -165.35	-122.05	-145.10	-147.96	-154.10
Income/Loss From Continuing Operations Before Tax	34.15% -170.23	-126.89	-159.00	-159.10	-163.48
Income Tax Expense/Benefit	112.29% 0.455	-3.702	0.65	0.732	0.495
Income/Loss From Continuing Operations After Tax	38.55% -170.68	-123.19	-159.65	-159.83	-163.97
Net Income/Loss	38.55% -170.68	-123.19	-159.65	-159.83	-163.97
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,198% 84.29	2.5561	71.66	70.90	70.37
Diluted Average Shares	3,198% 84.29	2.5561	71.66	70.90	70.37
Basic Earnings Per Share	40.97% -2.03	-1.44	-2.23	-2.25	-2.33
Diluted Earnings Per Share	40.97% -2.03	-1.44	-2.23	-2.25	-2.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

1.80%

INCY

$70.68

0.42%

MRNA

$38.38

3.49%

UTHR

$369.83

1.48%

BGNE

$196.58

0.88%

BNTX

$102.64

0.27%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters